WO2002074783A3 - Modified interferon beta with reduced immunogenicity - Google Patents
Modified interferon beta with reduced immunogenicity Download PDFInfo
- Publication number
- WO2002074783A3 WO2002074783A3 PCT/EP2002/002925 EP0202925W WO02074783A3 WO 2002074783 A3 WO2002074783 A3 WO 2002074783A3 EP 0202925 W EP0202925 W EP 0202925W WO 02074783 A3 WO02074783 A3 WO 02074783A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- interferon beta
- polypeptides
- reduced immunogenicity
- modified interferon
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002573792A JP2004529633A (en) | 2001-03-15 | 2002-03-15 | Modified human interferon beta with reduced immunogenicity |
PL02362870A PL362870A1 (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
US10/471,894 US7381795B2 (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
CA002441095A CA2441095A1 (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
KR10-2003-7011997A KR20030084992A (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
EP02726180A EP1368377A2 (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
BR0208041-9A BR0208041A (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
HU0303534A HUP0303534A3 (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
MXPA03008310A MXPA03008310A (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity. |
US12/077,120 US7615615B2 (en) | 2001-03-15 | 2008-03-17 | Modified interferon beta with reduced immunogenicity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01106539 | 2001-03-15 | ||
EP01106539.8 | 2001-03-15 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10471894 A-371-Of-International | 2002-03-15 | ||
US12/077,120 Division US7615615B2 (en) | 2001-03-15 | 2008-03-17 | Modified interferon beta with reduced immunogenicity |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002074783A2 WO2002074783A2 (en) | 2002-09-26 |
WO2002074783A3 true WO2002074783A3 (en) | 2003-08-28 |
Family
ID=8176796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/002925 WO2002074783A2 (en) | 2001-03-15 | 2002-03-15 | Modified interferon beta with reduced immunogenicity |
Country Status (13)
Country | Link |
---|---|
US (2) | US7381795B2 (en) |
EP (1) | EP1368377A2 (en) |
JP (1) | JP2004529633A (en) |
KR (1) | KR20030084992A (en) |
CN (1) | CN1496369A (en) |
BR (1) | BR0208041A (en) |
CA (1) | CA2441095A1 (en) |
HU (1) | HUP0303534A3 (en) |
MX (1) | MXPA03008310A (en) |
PL (1) | PL362870A1 (en) |
RU (1) | RU2003129072A (en) |
WO (1) | WO2002074783A2 (en) |
ZA (1) | ZA200307992B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2441095A1 (en) * | 2001-03-15 | 2002-09-26 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Modified interferon beta with reduced immunogenicity |
WO2003074561A1 (en) * | 2002-03-02 | 2003-09-12 | University Of South Florida | A method for treating allergic disease and asthma by recombinant adenovirus-and adeno-associated virus-mediated ifn-ϝ gene |
US7354908B2 (en) * | 2002-04-30 | 2008-04-08 | University Of South Florida | Materials and methods for prevention and treatment of RNA viral diseases |
EP1578772B1 (en) * | 2002-05-01 | 2010-05-12 | Danisco US Inc. | Cytokines and cytokine receptors with reduced immunogenicity |
US7595303B1 (en) | 2002-09-05 | 2009-09-29 | University Of South Florida | Genetic adjuvants for immunotherapy |
CA2498319A1 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
CA2516188C (en) * | 2003-02-14 | 2012-04-17 | University Of South Florida | Chitosan-derivatives for gene delivery and expression |
WO2005003157A2 (en) * | 2003-06-10 | 2005-01-13 | Xencor, Inc. | Interferon variants with improved properties |
WO2005105136A1 (en) * | 2004-04-27 | 2005-11-10 | University Of South Florida | Nanogene therapy for cell proliferation disorders |
US7670595B2 (en) * | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
WO2007110231A2 (en) * | 2006-03-28 | 2007-10-04 | Nautilus Biotech, S.A. | MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES |
US7884184B2 (en) | 2007-01-30 | 2011-02-08 | Epivax, Inc. | Regulatory T cell epitopes, compositions and uses thereof |
WO2008137471A2 (en) | 2007-05-02 | 2008-11-13 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
CA2691539C (en) * | 2007-06-21 | 2014-08-26 | Angelica Therapeutics, Inc. | Modified toxins |
US8470314B2 (en) * | 2008-02-29 | 2013-06-25 | Angelica Therapeutics, Inc. | Modified toxins |
CA2759333A1 (en) * | 2009-04-22 | 2010-10-28 | Merck Patent Gmbh | Antibody fusion proteins with modified fcrn binding sites |
SG10201602076QA (en) | 2011-10-01 | 2016-04-28 | Glytech Inc | Glycosylated polypeptide and pharmaceutical composition containing same |
JP2016519651A (en) | 2013-03-15 | 2016-07-07 | アンジェリカ セラピューティックス,インク. | Modified toxin |
CN104334574B (en) | 2013-03-29 | 2020-01-14 | 株式会社糖锁工学研究所 | Sialylated sugar chain-added polypeptide |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737462A (en) * | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
US4738844A (en) * | 1983-07-01 | 1988-04-19 | G. D. Searle & Co. | Modified (1-28) beta interferons |
WO1998052976A1 (en) * | 1997-05-21 | 1998-11-26 | Biovation Limited | Method for the production of non-immunogenic proteins |
WO2000034317A2 (en) * | 1998-12-08 | 2000-06-15 | Biovation Limited | Method for reducing immunogenicity of proteins |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2265693T3 (en) * | 1998-10-16 | 2007-02-16 | Biogen Idec Ma Inc. | FUSION PROTEINS WITH INTERFERON-BETA AND USES. |
US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
US6531122B1 (en) * | 1999-08-27 | 2003-03-11 | Maxygen Aps | Interferon-β variants and conjugates |
CA2441095A1 (en) * | 2001-03-15 | 2002-09-26 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Modified interferon beta with reduced immunogenicity |
-
2002
- 2002-03-15 CA CA002441095A patent/CA2441095A1/en not_active Abandoned
- 2002-03-15 BR BR0208041-9A patent/BR0208041A/en not_active IP Right Cessation
- 2002-03-15 KR KR10-2003-7011997A patent/KR20030084992A/en not_active Application Discontinuation
- 2002-03-15 US US10/471,894 patent/US7381795B2/en not_active Expired - Fee Related
- 2002-03-15 WO PCT/EP2002/002925 patent/WO2002074783A2/en active Application Filing
- 2002-03-15 RU RU2003129072/13A patent/RU2003129072A/en not_active Application Discontinuation
- 2002-03-15 JP JP2002573792A patent/JP2004529633A/en active Pending
- 2002-03-15 PL PL02362870A patent/PL362870A1/en unknown
- 2002-03-15 EP EP02726180A patent/EP1368377A2/en not_active Withdrawn
- 2002-03-15 CN CNA028065972A patent/CN1496369A/en active Pending
- 2002-03-15 HU HU0303534A patent/HUP0303534A3/en unknown
- 2002-03-15 MX MXPA03008310A patent/MXPA03008310A/en unknown
-
2003
- 2003-10-14 ZA ZA200307992A patent/ZA200307992B/en unknown
-
2008
- 2008-03-17 US US12/077,120 patent/US7615615B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737462A (en) * | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
US4738844A (en) * | 1983-07-01 | 1988-04-19 | G. D. Searle & Co. | Modified (1-28) beta interferons |
WO1998052976A1 (en) * | 1997-05-21 | 1998-11-26 | Biovation Limited | Method for the production of non-immunogenic proteins |
WO2000034317A2 (en) * | 1998-12-08 | 2000-06-15 | Biovation Limited | Method for reducing immunogenicity of proteins |
Non-Patent Citations (5)
Title |
---|
ALTUVIA Y ET AL: "RANKING POTENTIAL BINDING PEPTIDES TO MHC MOLECULES BY A COMPUTATIONAL THREADING APPROACH", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 249, no. 1, 1995, pages 244 - 250, XP000925520, ISSN: 0022-2836 * |
KERN FLORIAN ET AL: "T-cell epitope mapping by flow cytometry", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 4, no. 8, August 1998 (1998-08-01), pages 975 - 978, XP002155683, ISSN: 1078-8956 * |
KWOK W W ET AL: "Rapid epitope identification from complex class-II-restricted T-cell antigens", TRENDS IN IMMUNOLOGY, ELSEVIER, CAMBRIDGE, GB, vol. 22, no. 11, 1 November 2001 (2001-11-01), pages 583 - 588, XP004319746, ISSN: 1471-4906 * |
PORTER A G ET AL: "NOVEL MODIFIED BETA INTERFERONS GENE CLONING EXPRESSION AND BIOLOGICAL ACTIVITY IN BACTERIAL EXTRACTS", DNA (NEW YORK), vol. 5, no. 2, 1986, pages 137 - 148, XP009004132, ISSN: 0198-0238 * |
STEWART A G ET AL: "Chemical mutagenesis of human interferon-beta: construction, expression in E. coli, and biological activity of sodium bisulfite-induced mutations.", DNA (MARY ANN LIEBERT, INC.) UNITED STATES APR 1987, vol. 6, no. 2, April 1987 (1987-04-01), pages 119 - 128, XP009004161, ISSN: 0198-0238 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002074783A2 (en) | 2002-09-26 |
US7381795B2 (en) | 2008-06-03 |
RU2003129072A (en) | 2005-04-20 |
US20050054052A1 (en) | 2005-03-10 |
CA2441095A1 (en) | 2002-09-26 |
US7615615B2 (en) | 2009-11-10 |
BR0208041A (en) | 2004-02-25 |
PL362870A1 (en) | 2004-11-02 |
EP1368377A2 (en) | 2003-12-10 |
HUP0303534A3 (en) | 2005-12-28 |
US20090043076A1 (en) | 2009-02-12 |
ZA200307992B (en) | 2005-01-14 |
CN1496369A (en) | 2004-05-12 |
MXPA03008310A (en) | 2003-12-11 |
JP2004529633A (en) | 2004-09-30 |
HUP0303534A2 (en) | 2004-01-28 |
KR20030084992A (en) | 2003-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002074783A3 (en) | Modified interferon beta with reduced immunogenicity | |
WO2002062832A3 (en) | Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity | |
WO2002062833A3 (en) | Modified leptin with reduced immunogenicity | |
WO2002062843A3 (en) | Modified erythropoietin (epo) with reduced immunogenicity | |
WO2002085941A3 (en) | Modified interferon alpha with reduced immunogenicity | |
WO2003040398A3 (en) | Proteins stabilized with polysaccharide gums | |
WO2002070548A3 (en) | Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity | |
WO2002070698A3 (en) | Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity | |
WO2003037272A3 (en) | Thymosin alpha 1 peptide/polymer conjugates | |
WO2003006047A3 (en) | Methods for reducing immunogenicity of polypeptides | |
WO2002068469A3 (en) | Modified thrombopoietin with reduced immunogenicity | |
WO2002077034A3 (en) | Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity | |
WO2004035602A3 (en) | Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines | |
WO2002074808A3 (en) | Modified insulin with reduced immunogenicity | |
EP1173476A4 (en) | Soybean protein nutraceuticals | |
WO2003093298A3 (en) | Immunogenic peptides | |
BR0207017A (en) | Modified keratinocyte growth factor (kgf) with reduced immunogenicity | |
WO2002078607A3 (en) | Mucin peptide with immunoenhancing properties | |
WO2003014293A3 (en) | Novel polypeptide analogs and fusions and their methods of use | |
IL85204A0 (en) | Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002726180 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002256681 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2441095 Country of ref document: CA Ref document number: 10471894 Country of ref document: US Ref document number: PA/a/2003/008310 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 028065972 Country of ref document: CN Ref document number: 1020037011997 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002573792 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/07992 Country of ref document: ZA Ref document number: 200307992 Country of ref document: ZA |
|
WWP | Wipo information: published in national office |
Ref document number: 2002726180 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |